Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States-Reference-Cited by-同舟云学术

Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States

Published:2022-07-25 Issue:11 Volume:21 Page:1691-1696
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Hatziantoniou Sophia¹^ORCID,Anastassopoulou Cleo²^ORCID,Lazaros George³,Vasileiou Konstantinos⁴,Tsioufis Costas³,Tsakris Athanasios²^ORCID

Affiliation:

1. Laboratory of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece

2. Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

3. First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece

4. Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2022.2100765

Reference19 articles.

1. The story behind COVID-19 vaccines

2. The lightning-fast quest for COVID vaccines — and what it means for other diseases

3. Messengers of hope

4. European Medicines Agency. EudraVigilance-European database of suspected adverse drug reaction reports and European Centre for disease prevention and control, COVID-19 vaccine tracker. [cited 2021 Oct 8]. Available from: https://www.adrreports.eu

5. Vaccine Adverse Event Reporting System. 2021 [cited 2021 Oct 15]. Available from: https://vaers.hhs.gov/data.html.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Russian COVID-19 vaccines as a risk factor of myopericarditis in patients with or without previous infection;Russian Journal of Cardiology and Cardiovascular Surgery;2024

2. Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines;Frontiers in Cardiovascular Medicine;2023-11-24

3. Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination;Vaccine;2023-11

4. COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences;Pathology - Research and Practice;2023-06

5. The person‐time ratio distribution for the exact monitoring of adverse events: Historical vs surveillance Poisson data;Statistics in Medicine;2023-05-23